Zobrazeno 1 - 10
of 198
pro vyhledávání: '"Trivadi, S. Ganesan"'
Autor:
Venkatraman Radhakrishnan, Sameer Bakhshi, Smita Kayal, Cherian Thampy, Ankit Batra, Praveen Kumar Shenoy, Hemanth Kumar, Swaminathan Rajaraman, Shilpi Chaudhary, Reema Bisht, Biswajit Dubashi, Trivadi S. Ganesan
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-10 (2022)
Abstract The benefit of three-drug induction chemotherapy over a two-drug induction has not been evaluated in pediatric acute myeloid leukemia (AML). We, therefore, conducted a randomized controlled trial to ascertain the benefit of a three-drug indu
Externí odkaz:
https://doaj.org/article/06a7de0642e74c8092c44bd295d75677
Autor:
Parathan Karunakaran, Gangothri Selvarajan, Jayachandran Perumal Kalaiyarasi, Nikita Mehra, Shirley Sundersingh, Manikandan Dhanushkodi, Sivasree Kesana, Krishnarathinam Kannan, Trivadi S Ganesan, Venkatraman Radhakrishnan, Tenali Gnana Sagar
Publikováno v:
South Asian Journal of Cancer, Vol 11, Iss 01, Pp 068-072 (2022)
Abstract The nomenclature high-grade non-Hodgkin's lymphoma was repurposed in the World Health Organization (WHO) 2016 update as high-grade B cell lymphoma (HGBL). However, among the HGBL entities HGBL, not otherwise specified (NOS) remains a poorly
Externí odkaz:
https://doaj.org/article/64de450a1bbd433aa5769b7566be1ed5
Locally Advanced Breast Cancer (LABC): Real-World Outcome of Patients From Cancer Institute, Chennai
Autor:
Manikandan Dhanushkodi, Velusamy Sridevi, Viswanathan Shanta, Ranganathan Rama, Rajaraman Swaminathan, Ganesarajah Selvaluxmy, Trivadi S. Ganesan
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 767-781 (2021)
PURPOSEThere are sparse data on the outcome of patients with locally advanced breast cancer (LABC). This report is on the prognostic factors and long-term outcome from Cancer Institute, Chennai.METHODSThis is an analysis of untreated patients with LA
Externí odkaz:
https://doaj.org/article/39c053e1c66e440e98eb8d4a5f6eee2c
Autor:
Hemanth Kumar, S.V. Saju, Venkatraman Radhakrishnan, Anand Raja, Trivadi S. Ganesan, Manikandan Dhanushkodi, Jayachandran Perumal Kalaiarasi, Nikita Mehra, Archit Joshi, Arun Kumar Rajan, Gangothri Selvarajan, Tenali Gnana Sagar
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 5, Iss 2, Pp 37-42 (2020)
Background: Extra-cranial germ cell tumors (GCT) are rare malignancies in children. There is paucity of data on presentation and outcomes of extra-cranial GCT in male children from India. Methods: The study included all extra-cranial GCT in male chil
Externí odkaz:
https://doaj.org/article/e4da84ece03b4788bd51c066e9bebf3b
Autor:
Siva Sree Kesana, Prasanth Ganesan, Tenali Gnana Sagar, Krishnarathinam Kannan, Trivadi S Ganesan, Manikandan Danushkodi, Nikita Mehra, P K Jayachandran, Archit Joshi, Arun Kumar, Gangothri Selvarajan, Shirley Sundersingh, Venkatraman Radhakrishnan
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 3-12 (2020)
Background: Peripheral T-cell lymphomas (PTCL) are a heterogeneous group of diseases with aggressive behavior and inferior outcomes as compared to B-cell lymphomas. We report the outcomes from a single center over a period of 18 years. Methods: The b
Externí odkaz:
https://doaj.org/article/34b5199e90304b409cf4e91725e16872
Autor:
Kiran Kumar, Venkatraman Radhakrishnan, Manikandan Dhanushkodi, Jayachandran Perumal Kalaiyarasi, Nikita Mehra, Arun Rajan Kumar, Gangothri Selvarajan, Trivadi S Ganesan, Tenali Gnana Sagar
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 1, Pp 64-68 (2020)
Introduction: Oral metronomic chemotherapy (OMC) is a less intensive and cost-effective palliative treatment modality in children with relapsed/refractory cancers in low-middle income countries. We aimed to study the safety and efficacy of OMC with o
Externí odkaz:
https://doaj.org/article/8b1da851e78e4dc49fdc2293809fa809
Autor:
Indhuja Muthiah Vaikundaraja, Manikandan Dhanushkodi, Venkatraman Radhakrishnan, Jayachandran Perumal Kalaiarasi, Nikita Mehra, Arun Kumar Rajan, Gangothri Selvarajan, Siva Sree Kesana, Balasubramanian Ananthi, Priya Iyer, Geetha Senguttuvan, Manjula Rao, Arvind Krishnamurthy, Sridevi Velusamy, Hemanth Raj, Rama Ranganathan, Shirley Sundersingh, Selvaluxmy Ganesarajah, Trivadi S Ganesan, Tenali Gnana Sagar
Publikováno v:
Cancer Research, Statistics, and Treatment, Vol 3, Iss 2, Pp 275-280 (2020)
Background: Fulvestrant has been shown to improve survival in hormone-positive, HER2-negative advanced breast cancer (ABC). There is no study on fulvestrant from India. Objectives: This study was done to assess the prognostic factors and outcome of p
Externí odkaz:
https://doaj.org/article/fd6bf614752c4471ae3f7a154a33a3e5
Autor:
Venkatraman Radhakrishnan, Perraju Bhaskar Bhuvan Lagudu, Devleena Gangopadhyay, Varalakshmi Vijaykumar, Swaminathan Rajaraman, Jayachandran Perumal Kalaiyarasi, Prasanth Ganesan, Trivadi S. Ganesan
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 4, Pp S3- (2022)
Externí odkaz:
https://doaj.org/article/5b98624d9a5e4b0882c9d5c4cd7f70f4
Autor:
Venkatraman Radhakrishnan, Sameer Bakhshi, Smita Kayal, Cherian Thampy, Ankit Batra, Praveen Kumar Shenoy, Hemanth Kumar, Shilpi Chaudhary, Swaminathan Rajaraman, Reema Bisht, Biswajit Dubashi, Trivadi S. Ganesan
Publikováno v:
Pediatric Hematology Oncology Journal, Vol 7, Iss 4, Pp S6- (2022)
Externí odkaz:
https://doaj.org/article/14f270dfe08d487aa6f7537a7c9590d7
Autor:
Venkatraman Radhakrishnan, Sameer Bakhshi, Smita Kayal, Cherian Thampy, Ankit Batra, Praveen Kumar Shenoy, Hemanth Kumar, Swaminathan Rajaraman, Shilpi Chaudhary, Reema Bisht, Biswajit Dubashi, Trivadi S. Ganesan
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 9, Pp 1-1 (2022)
Externí odkaz:
https://doaj.org/article/766e082e036b44be87009d1a096ae263